Vimarsana
Biggest News Aggregation in the World

Pharmaceutical Scientists News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Pharmaceutical Scientists. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Pharmaceutical Scientists Today - Breaking & Trending Today

2024 INTERPHEX Conference - Events on SelectScience - Vimarsana News

2024 INTERPHEX Conference - Events on SelectScience

Published: April 12, 2024

Events on SelectScience

Source: selectscience.net
Related Topics:
United StatesAmerican Association Of Pharmaceutical ScientistsAmerican AssociationPharmaceutical Scientists
Ensysce Biosciences Issues 2024 Shareholder Letter - Vimarsana News

Ensysce Biosciences Issues 2024 Shareholder Letter

Published: January 8, 2024

Ensysce Biosciences Issues 2024 Shareholder Letter

Source: pr-inside.com
Related Topics:
United StatesLynn KirkpatrickEnsysce Biosciences IncCollege On Problems Of Drug DependenceChemical Associated Technologies AssociationNews NetworkEuropean Pharmaceutical Market Research AssociationAmerican Association Of Pharmaceutical ScientistsEnsysce BiosciencesChief Executive OfficerFellow ShareholdersNext GenerationHelping End Addiction Long TermMeeting DrugAssociated Technologies AssociationWeek The CollegeDrug DependenceAnnual Conference The Controlled Release SocietyExpo The American AssociationPharmaceutical ScientistsFierce New Product Planning SummitAnnual Pain Therapeutics SummittheInvestigational Review BoardPlacebo Controlled Crossover StudyAnalgesic Response
Aliasger K. Salem - Vimarsana News

Aliasger K. Salem

Published: November 27, 2023

Aliasger K. Salem’s profile on The Conversation

Source: theconversation.com
Related Topics:
United StatesUnited KingdomAliasger SalemAmerican Institute ForProfessor Of Pharmaceutical SciencesLeadership In Research AwardAmerican Association For The Advancement Of ScienceResearch For The University Of IowaAston University Of ScienceAmerican Association For Pharmaceutical ScientistsDepartment Of DefenseAmerican Cancer SocietyHolden Comprehensive Cancer CenterJohns Hopkins School Of MedicineNational Institutes For HealthUniversity Of NottinghamUniversity Of IowaResearch ProgramsEnvironmental Health Sciences Research CenterAssociate Vice PresidentBighley ChairPharmaceutical SciencesAmerican AssociationPharmaceutical ScientistsExperimental Therapeutics Program
Pulmatrix Announces Third Quarter 2023 Financial Results and Provides Corporate Update - Vimarsana News

Pulmatrix Announces Third Quarter 2023 Financial Results and Provides Corporate Update

Published: November 9, 2023

/PRNewswire/ -- Pulmatrix, Inc. (Nasdaq: PULM), a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary...

Source: prnewswire.com
Related Topics:
United StatesUnited KingdomBorough Of BedfordTimothy MccarthyTed RaadAmerican Academy Of AllergyAmerican Headache SocietyCompany Quarterly Reports On FormExchange CommissionPrnewswire Pulmatrix IncPulmatrix IncAmerican Association Of Pharmaceutical ScientistsChief Executive OfficerRecent ProgramAmerican AssociationPharmaceutical ScientistsDrug InteractionsAnnual MeetingAmerican AcademyCipla AgreementChronic Obstructive Pulmonary DiseaseAnnual ReportQuarterly ReportsCurrent ReportsPulmatrix Inc
Scilex Holding Company Announces New Data From Deeper Skin Penetration Studies to Support SP-103 (lidocaine topical system) 5.4%, a Triple Strength Formulation of ZTlido®, in Treatment of Musculoskeletal Pain Disorders - Vimarsana News

Scilex Holding Company Announces New Data From Deeper Skin Penetration Studies to Support SP-103 (lidocaine topical system) 5.4%, a Triple Strength Formulation of ZTlido®, in Treatment of Musculoskeletal Pain Disorders

Published: November 2, 2023

PALO ALTO, Calif., Nov. 02, 2023 -- Scilex Holding Company , an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for...

Source: marketscreener.com
Related Topics:
United StatesPalo AltoDmitri LissinMultidisciplinary Digital Publishing InstituteScilex Or CompanyAmerican Association Of Pharmaceutical ScientistsInstitute For Biomedical ResearchDrug AdministrationScilex Holding Company NasdaqScilex Holding Company All RightsScilex Holding CompanyGlobenewswire IncPivotal Trialc Le Ar ProgramSemnur Pharmaceuticals IncScilex Pharmaceuticals IncExchange CommissionHolding CompanyBiomedical ResearchPharmaceutical ScientistsDigital Publishing InstituteTopical DeliveryPost Herpetic NeuralgiaChief Medical OfficerLumbosacral Radicular PainPrivate Securities Litigation Reform Act